On 5 September 2012 the European Commission decision amending Decision 2000/96/EC as regards tick-borne encephalitis was published. As a result tick-borne encephalitis is added to the list of diseases to be covered by epidemiological surveillance within the Community.
The study compares the incidence and serotype distribution of invasive pneumococcal disease (IPD) for pneumococcal meningitis and non-meningitis IPD in children from 2007 to 2010 with reference to the pre-vaccination period from 1997 to 2001 in Germany.
ECDC, through the VBORNET network, publishes regularly on its website maps on exotic mosquitoes and on phlebetomines - to provide the ECDC stakeholders and the general public with the most updated information on vector distribution. The maps are updated and improved quarterly.
This study found a marked reduction in vaccine serotype carriage after PCV7 implementation. The overall pneumococcal, H. influenzae and S. aureus carriage decreased slightly, but not significantly.
This study demonstrates that PCV13 is immunogenic and safe in children previously vaccinated with PCV7. By eliciting high antibacterial immune responses to the additional serotypes, PCV13 provides protection against these serotypes, which are important causes of pneumococcal disease globally.
The evidence presented in the article strongly supports the notion that serotype replacement has occurred in invasive pneumococcal disease in most populations and is caused by the vaccine.
Slovenia is one of the countries with the highest reported incidence rates of tick-borne encephalitis (TBE). Vaccination uptake is low, estimated to be 12.4%. TBE surveillance data for the last 20 years were analysed.
This study analyses occurence, trendline, occurence by months and geographical distribution of tick-transmitted diseases: Lyme borreliosis, Tick-borne meningoencephalitis (TBM) and Mediterranean spotted fever in the Republic of Croatia in the period between 1999 and 2008.